Researchers report favorable safety and efficacy for a combination device after implantation and at 6 months follow-up among ...
WASHINGTON, DC — Levels of several biomarkers of inflammation, neurohormonal status, and cardiac injury, collectively and together, were independent predictors of all-cause mortality but, with one ...
On top of performing implantable cardioverter-defibrillator (ICD) functions, the integrated device also delivered appropriate ...
Ablation, a procedure to treat abnormal electrical short circuits caused by a heart attack and is usually reserved for patients who do not improve with medication, may be a better first-line treatment ...
CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation improved outcomes compared with trying antiarrhythmic drugs first, the VANISH2 ...
Please provide your email address to receive an email when new articles are posted on . Catheter ablation improved outcomes vs. antiarrhythmic drugs in patients with VT and ischemic cardiomyopathy.
SAN DIEGO, CA—Catheter ablation for ventricular arrhythmias is beneficial for patients with ischemic cardiomyopathy, affirms a new meta-analysis updated to include the VANISH2 trial results. Compared ...